“With every innovation comes differences of opinions,” says Mark Atkinson, Chair of the Planning Committee for this year’s ADA Scientific Sessions. In this Day 1 edition of the EASD e-Learning Newsflash, he shares key innovations to watch and highlights controversial questions being tackled through an expanded debate format. Alice Cheng recounts her arguments in favour of SGLT2 inhibitors in a debate on which glucose-lowering medications should be prioritised in type 2 diabetes. Chair of the EASD Training and Education Committee Julia Mader weighs in on a debate over whether CGM should be available over-the-counter (OTC), the push for better CGM accuracy standards in the European Union, and emerging research on how a mother’s diet during pregnancy may shape long-term metabolic risks in her child.  

Interviewees:  

• Prof. Mark Atkinson, University of Florida  
• Assoc Prof. Alice Cheng, University of Toronto  
• Prof. Julia Mader, Medical University of Graz 

Staff: 

• Interviewer: Dr Albert Brugger
• Videographer: Christian Fichtner, Bsc